A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2006
12/06/2006	CN1872253A Method for controlling quality of Yunnan red tablet
12/06/2006	CN1872242A Injection preparation of leaf of nakedflower beautyberry, and preparation method
12/06/2006	CN1872236A Medication for treating aplastic anemia
12/06/2006	CN1872234A Composition of medication for inducing diuresis to alleviate edema, preparing and controlling quality method, usage
12/06/2006	CN1872202A Method for preparing medication of replenishing qi and the blood
12/06/2006	CN1872182A Medication for treating thalassemia and preparation method
12/06/2006	CN1872150A Composition of Chinese traditional medicine for replenishing qi and the blood
12/06/2006	CN1872136A Medication for treating neonatal jaundice, and method of use.
12/06/2006	CN1872087A Medication of possessing function of anti inflammation, for improving rheological property of blood, and restraining thrombosis
12/06/2006	CN1872083A Application of monarda glycoside in preparing medicine for treating or preventing hemorrhagic disease
12/06/2006	CN1872082A Application of 'Menghuagan' in preparing medicine for treating or preventing hemorrhagic disease
12/06/2006	CN1872072A Nano emulsion injection of alprostadil and preparation method
12/06/2006	CN1872064A Drop pills of piperazine ferulic acid, and preparation method
12/06/2006	CN1872054A Drop pills of coumarin acetic acid, and preparation method
12/06/2006	CN1872051A Dry suspensoid of ginkgolide, and preparation method
12/06/2006	CN1872046A Drop pills of soybean aglycone, and preparation method
12/06/2006	CN1872032A Torasemide soft capsule, and preparation method
12/06/2006	CN1288245C Long-noded pit viper dissolving fiber protein No.4 gene and use thereof
12/06/2006	CN1288170C Sulphatization derivative of polysaccharide, its preparation method and use
12/06/2006	CN1288148C 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
12/06/2006	CN1288135C Certain 1-(D-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor XA
12/06/2006	CN1287827C Blood-supplementing traditional Chinese medicine preparation and its production method
12/06/2006	CN1287822C Oral liquid for treating paramenia and dys functional uterine bleeding
12/06/2006	CN1287784C Troxerution guttate pill and preparation method thereof
12/05/2006	US7145009 Pirazino(aza)indole derivatives
12/05/2006	US7144912 drugs such as (4-methoxy-5-(1H-indol-2yl-methylene)-2,2'-bi-1H-pyrrole) used as anticarcinogenic or antitumor agents
12/05/2006	US7144902 Prodrugs of thrombin inhibitors
12/05/2006	US7144899 Thrombin inhibitors
12/05/2006	US7144892 Treatment of cardiovascular and related pathologies
12/05/2006	US7144883 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
12/05/2006	US7144873 Therapy for anticancer agents, blood disorders; dissolving in nonaqueous solvent
12/05/2006	US7144872 1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-carboxamides; adenosine receptors (A2A); for stimulating mammalian coronary vasodilatation for therapy and imaging the heart
12/05/2006	US7144863 Powders of glucagon-like peptide is complexed with a polypeptide of polylysine, polyarginine, polyornithine, protamine, putrescine, spermine, spermidine, and histone; treating diabetes, hyperglycemia, obesity, irritable bowel syndrome, myocardial infarction; drug delivery by inhalation
12/05/2006	CA2396458C Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
11/2006
11/30/2006	WO2006126676A1 Cyclic amine derivative having substituted alkyl group
11/30/2006	WO2006126523A1 Peritoneum protecting agent
11/30/2006	WO2006076575B1 Substituted biaryl compounds as factor xia inhibitors
11/30/2006	US20060270728 Substituted dihydropyrano indole-3,4-dione derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/30/2006	US20060270719 2-[(Cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-2-yl-benzyl)-amino]-N-hydroxy-acetamide; selective inhibitors of matrix-degrading metalloproteinases, especially MT1-MMP, MMP-2 and MMP-9; Osteoporosis; Antitumor, antiproliferative agents
11/30/2006	US20060270717 Therapeutic combination
11/30/2006	US20060270706 Cyclic amine derivative having heteroaryl ring
11/30/2006	US20060270699 Stabilization of hypoxia inducible factor (HIF) alpha
11/30/2006	US20060270681 Pyridazine derivatives
11/30/2006	US20060270679 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/30/2006	US20060270607 Pharmaceutical combinations
11/30/2006	US20060270002 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060270001 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060270000 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060269912 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
11/30/2006	US20060269565 Administering a polypeptide fused to an Fc, has T-cell proliferation inhibiting activity to treat autoimmune encephalomyelitis
11/30/2006	US20060269511 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
11/30/2006	DE102005023666A1 Use of marmot oils for the treatment of skin diseases such as acne vulgaris, acne rosacea, neurodermitits, phlebitis, herpes or external hemorrhoids
11/30/2006	CA2624090A1 Peritoneum protecting agent
11/30/2006	CA2609852A1 Cyclic amine derivative having substituted alkyl group
11/29/2006	EP1726647A1 Gene promoting vascular endothelial cell growth
11/29/2006	EP1726303A1 Therapeutic agent for renal anemia
11/29/2006	EP1725577A1 Antithrombotic compound
11/29/2006	EP1725550A2 Pyrrole-derivatives as factor xa inhibitors
11/29/2006	EP1725243A2 Boronate medicaments for preventing thrombosis during surgery
11/29/2006	EP1725242A2 Boronate medicaments suitable for short duration anticoagulation
11/29/2006	EP1725220A1 Effervescent formulations comprising desmopressin
11/29/2006	EP1553947A4 Quinazolinones and derivatives thereof as factor xa inhibitors
11/29/2006	EP1259223A4 Protein matrix materials, devices and methods of making and using thereof
11/29/2006	EP1218403B1 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
11/29/2006	EP1012281B1 Human leukocyte calcium activated potassium channel polypeptide
11/29/2006	EP0973541B1 Use of histons for the production of medicaments
11/29/2006	EP0788546B1 Nematode-extracted serine protease inhibitors and anticoagulant proteins
11/29/2006	CN1871224A 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
11/29/2006	CN1869051A Preparation method of trialcohol group ginseng saponine and dialcohol group ginseng saponine
11/29/2006	CN1868544A Amino-acid modified chitin nucleophic NO donor and its synthesis method
11/29/2006	CN1868533A Traditional Chinese medicine soft capsule for eliminating thrombus and removing obstruction in channels, its prepn. method
11/29/2006	CN1868516A Medicine for treating fracture and injury
11/29/2006	CN1868498A Gutweed total flavone, its prepn. method, freeze-drying powder injection containing it and quality control method therefor
11/29/2006	CN1868482A Aspirin slow-release tablet and its prepn. method
11/29/2006	CN1286974C Mutant of recombined glucokinase for anti blood platelet collecting and low immunogenic
11/29/2006	CN1286812C Bispiperidines as antithrombotic agents
11/29/2006	CN1286805C Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
11/29/2006	CN1286511C Preparing method of freeze-dried powder injection for treatment of cardiovascular disease
11/29/2006	CN1286469C Pharmaceutical use of isolarisiresinol
11/29/2006	CN1286456C Luolai compositions useful for the treatment of type-2 synalbumin diabetes pharmaceutical application
11/29/2006	CN1286455C Pharmaceutical use of 5-hydroxymethyl furfural
11/28/2006	US7141672 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/28/2006	US7141653 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders
11/28/2006	US7141599 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin
11/28/2006	US7141592 Substituted oxadiazolidinediones
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	US7141558 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
11/28/2006	US7141547 Albumin fusion proteins comprising GLP-1 polypeptides
11/28/2006	US7141383 EDG8 receptor, its preparation and use
11/28/2006	US7141363 Purposeful movement of human migratory cells away from an agent source
11/28/2006	US7140497 Selective deleukocytation unit for a platelet product
11/28/2006	CA2379640C Certain alkylene diamine-substituted heterocycles
11/28/2006	CA2026915C Stem cell factor
11/28/2006	CA1341516C Preparation of factor x111a by gene manipulation
11/23/2006	WO2006123724A1 Novel pharmaceutical using anti-hla antibody
11/23/2006	WO2006123059A1 Medicament made from laminarine or oligolaminarines for treatment of septicemia and septic shock
11/23/2006	WO2006122661A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
11/23/2006	WO2006122476A1 A method of inactivating virus, treatment system and device used thereof
11/23/2006	WO2006105217A3 Spirocyclic thrombin receptor antagonists
11/23/2006	US20060264626 INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE

1 ... 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 ... 671